- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01564771
Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year. (B1851065)
30. november 2018 opdateret af: Pfizer
Serotype distribution and estimation of antimicrobial resistance in S. pneumoniae isolates and anticipated PCV7 and PCV13 coverage is difficult in Greece, because invasive isolates collected each year are limited and depict a certain proportion of patients who have easy access to tertiary care or have underlying medical reasons which necessitate inpatient care.
It is also probable that the real burden of pneumococcal disease is not well estimated especially among adults.
New additions in the laboratory setting such as the pneumococcal urine antigen assay (Binax NOW®) and the Urinary Antigen Diagnostic Assay (Luminex) for the detection of 13 serotype specific polysaccharides in human urine developed by Pfizer might be helpful in identifying more pneumococcal infections compared to the previous years.
This NIS is based on the unmet scientific need to describe the serotype distribution and the resistance profile of isolates from X-Ray confirmed CAP in the present circumstances.
Studieoversigt
Detaljeret beskrivelse
For each surveillance period lasting for 12 months all adults presenting in the selected clinics with symptoms and signs suggestive of pneumonia (candidate cases) will be asked to participate in the study
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
293
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Alexandroupoli, Grækenland, 68100
- General University Hospital of Alexandroupoli
-
Athens, Grækenland, 11527
- General Chest Diseases Hospital "Sotiria"/ 7th Department of Pulmonary Medicine
-
Athens, Grækenland, 11527
- General Hospital of Athens "Sotiria"/ 12Th Pneumonology Clinic
-
Athens, Grækenland, 11527
- General Hospital of Athens "Sotiria"/ 1St Pneumonology Clinic
-
Athens, Grækenland, 11527
- General Hospital of Athens "Sotiria"/ 2Nd Pneumonology Clinic
-
Athens, Grækenland, 11527
- General Hospital of Athens "Sotiria"/ 5Th Pneumonology Clinic
-
Athens, Grækenland, 11527
- General Hospital of Athens "Sotiria"/ 6Th Pneumonology Clinic
-
Athens, Grækenland, 11527
- General Hospital of Athens "Sotiria"/ 8Th Pneumonology Clinic
-
Athens, Grækenland, 15123
- Diagnostic Therapeutic Center of Athens Ygeia
-
Athens, Grækenland, 15126
- General Hospital Athens "Sismanoglio"/ 1St Pneumonology Clinic
-
Athens, Grækenland, 15126
- General Hospital of Athens "Sismanoglio" / 3Rd Pneumonology Department
-
Athens, Grækenland, 15126
- General Hospital of Athens "Sismanoglio"/ 2Nd Pneumonology Clinic
-
Athens, Grækenland, 15127
- General Hospital Mellision "Amalia Fleming"/ Pneumonology Clinic
-
Athens, Grækenland, 15127
- General Hospital Mellision "Amalia Fleming"/2nd Internal Medicine Department
-
Athens, Grækenland, 15227
- Sotiria Hospital, Intensive Care Unit
-
Athnens, Grækenland
- General University Hospital "Attikgeneral University Hospital "Attikon"/ 4Th University Internal Med
-
Kavala, Grækenland, 65201
- General Hospital of Kavala/ A Pneumonological Clinic
-
Kavala, Grækenland, 65201
- General Hospital of Kavala/ b Pneumonological & Tubeculosis Department
-
Larissa, Grækenland, 41 110
- University General Hospial of Larissa, Pneumonology Department
-
-
Attiki
-
Athens, Attiki, Grækenland
- General Hospital of Athens "Evangelismos" / Pneumonology Department
-
-
Evros
-
Alexandroupoli, Evros, Grækenland, 68100
- University Hospital of Alexandroupolis
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Adults ≥18 years of age with chest X-ray confirmed CAP
Beskrivelse
Inclusion Criteria:
- Patients who agreed to participate in the study and agreed to sign an ICD.
- Patients had to be ≥18 years of age (adults)
- Patients had to present or had been referred to a participating healthcare facility with suspected pneumonia based on the physician's assessment (including but not limited to specific signs and symptoms described in Section 9.3 of the protocol)
- Patients must have had a posteroanterior or anteroposterior chest X-ray showing an infiltrate (if previous films were not available) or a new infiltrate (if recent film was available)
- Patients had to be tested positive for the Binax NOW® assay (required post Protocol Amendment 2)
Exclusion Criteria:
- Patients who did not sign an ICD.
- Any patient who developed signs and symptoms of pneumonia after being hospitalized for ≥48 hours
- Any patient who was transferred to a study healthcare facility after already being hospitalized for ≥48 hours at another healthcare facility
- Patients who did not have a chest X-ray performed
- Patients who did not have the Binax NOW® assay performed
- Patients with negative results for the Binax NOW® assay (required post Protocol Amendment 2)
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kun etui
- Tidsperspektiver: Fremadrettet
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Group one
Adults ≥18 years of age with chest X-ray confirmed CAP
|
This Is A Non Interventional Study
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
The frequency of serotypes 4,6B,9V,14,18C,19F,23F,1,3,5,6A,7F and 19A from chest X-ray confirmed pCAP patients (post amendment2 with positive Binax NOW® only) who presented in the emergency departments of 15 hospitals in Greece during 1
Tidsramme: One year
|
One year
|
|
calendar year.
Tidsramme: One year
|
One year
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Susceptibility, resistance or partial resistance Streptococcus pneumoniae clinical isolates obtained from study adult CAP patients.
Tidsramme: One year
|
One year
|
|
The frequency of the 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 3, 5, 6A, 7F, 19A serotypes (based on Luminex assay) of study patients immunized and not immunized with PPV.
Tidsramme: One year
|
One year
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. januar 2011
Primær færdiggørelse (Faktiske)
1. april 2013
Studieafslutning (Faktiske)
1. april 2013
Datoer for studieregistrering
Først indsendt
26. marts 2012
Først indsendt, der opfyldte QC-kriterier
27. marts 2012
Først opslået (Skøn)
28. marts 2012
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
3. december 2018
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
30. november 2018
Sidst verificeret
1. november 2018
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- B1851065
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
produkt fremstillet i og eksporteret fra U.S.A.
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .